Background: Motor cortex stimulation (MCS) is being offered to patients suffering from neuropathic pain. Outcome prediction, programming and especially sustaining a long-term treatment effect represent major challenges. We report a retrospective long-term analysis of our patients treated with MCS over a median follow-up of 39.1 months. Objectives: To investigate the time course of the treatment effect in MCS for neuropathic pain. Methods: Twenty-three closely followed patients treated with MCS were retrospectively analyzed. Reduction in pain measured on a visual analogue scale (VAS) was defined as the primary outcome parameter. VAS pain level and adverse events were documented at the 1-, 3-, 6-, 12-, 18- and 24-month follow-ups. Results: The mean VAS under best medical treatment was 7.8 (SD 1.2, range 5-9) with escalation to 9.3 (SD 0.9, range 6-10) when the patients' medications were missed or delayed. About half of the patients (47.8%) experienced a satisfactory (>50%) reduction in pain during the first month of treatment. The best treatment results were seen at the 3-month follow-up (mean VAS 4.8, SD 1.9, -37.2% compared to baseline). A decline in the treatment effect was generally observed at the subsequent follow-up assessments. Six patients had their devices explanted during the follow-up period due to loss of treatment effect. Conclusions: In this study, MCS failed to provide long-term pain control for neuropathic pain. Many aspects of MCS still remain unclear, especially the neural circuits involved and their response to long-term stimulation. Means must be developed to overcome the problems in this promising technique.

Keywords:
Neuropathic pain, Motor cortex stimulation, Neuromodulation
1.
Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S: Treatment of thalamic pain by chronic motor cortex stimulation. Pacing Clin Electrophysiol 1991;14:131-134.
2.
Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S: Chronic motor cortex stimulation in patients with thalamic pain. J Neurosurg 1993;78:393-401.
3.
Canavero S, Bonicalzi V: Motor cortex stimulation. J Neurosurg 2001;94:688-689.
4.
Nguyen JP, Lefaucher JP, Le Guerinel C, Eizenbaum JF, Nakano N, Carpentier A, Brugieres P, Pollin B, Rostaing S, Keravel Y: Motor cortex stimulation in the treatment of central and neuropathic pain. Arch Med Res 2000;31:263-265.
5.
Rasche D, Ruppolt M, Stippich C, Unterberg A, Tronnier VM: Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10 year experience. Pain 2006;121:43-52.
6.
Fontaine D, Hamani C, Lozano A: Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg 2009;110:251-256.
7.
Nuti C, Peyron R, Garcia-Larrea L, Brunon J, Laurent B, Sindou M, Mertens P: Motor cortex stimulation for refractory neuropathic pain: four year outcome and predictors of efficacy. Pain 2005;118:43-52.
8.
Ebel H, Rust D, Tronnier V, Boker D, Kunze S: Chronic precentral stimulation in trigeminal neuropathic pain. Acta Neurochir (Wien) 1996;138:1300-1306.
9.
Velasco M, Velasco F, Brito F, Velasco AL, Nguyen JP, Marquez I, Boleaga B, Keravel Y: Motor cortex stimulation in the treatment of deafferentation pain. I. Localization of the motor cortex. Stereotact Funct Neurosurg 2002;79:146-167.
10.
Katayama Y, Yamamoto T, Kobayashi K, Oshima H, Fukaya C: Deep brain and motor cortex stimulation for post-stroke movement disorders and post-stroke pain. Acta Neurochir Suppl 2003;87:121-123.
11.
Henderson JM, Boongird A, Rosenow JM, LaPresto E, Rezai AR: Recovery of pain control by intensive reprogramming after loss of benefit from motor cortex stimulation for neuropathic pain. Stereotact Funct Neurosurg 2004;82:207-213.
12.
Thomas L, Bledsoe JM, Stead M, Sandroni P, Gorman D, Lee KH: Motor cortex and deep brain stimulation for the treatment of intractable neuropathic face pain. Curr Neurol Neurosci Rep 2009;9:120-126.
13.
Velasco F, Carrillo-Ruiz JD, Castro G, Arguelles C, Velasco AL, Kassian A, Guevara U: Motor cortex electrical stimulation applied to patients with complex regional pain syndrome. Pain 2009;147:91-98.
14.
Pagano RL, Fonoff ET, Dale CS, Ballester G, Teixeira MJ, Britto LR: Motor cortex stimulation inhibits thalamic sensory neurons and enhances activity of PAG neurons: possible pathways for antinociception. Pain 2012;153:2359-2369.
15.
Garcia-Larrea L, Peyron R, Mertens P, Gregoire MC, Lavenne F, Le Bars D, Convers P, Mauguiere F, Sindou M, Laurent B: Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 1999;83:259-273.
16.
Lefaucheur JP, Holsheimer J, Goujon C, Keravel Y, Nguyen JP: Descending volleys generated by efficacious epidural motor cortex stimulation in patients with chronic neuropathic pain. Exp Neurol 2010;223:609-614.
17.
Senapati AK, Huntington PJ, Peng YB: Spinal dorsal horn neuron response to mechanical stimuli is decreased by electrical stimulation of the primary motor cortex. Brain Res 2005;1036:173-179.
18.
Choi YH, Jung SJ, Lee CH, Lee SU: Additional effects of transcranial direct-current stimulation and trigger-point injection for treatment of myofascial pain syndrome: a pilot study with randomized, single-blinded trial. J Altern Complement Med 2014;20:698-704.
19.
Batsikadze G, Paulus W, Grundey J, Kuo MF, Nitsche MA: Effect of the nicotinic α4β2-receptor partial agonist varenicline on non-invasive brain stimulation-induced neuroplasticity in the human motor cortex. Cereb Cortex 2014, DOI: 10.1093/cercor/bhu126.
20.
May A: Chronic pain may change the structure of the brain. Pain 2008;137:7-15.
21.
Buchner H, Richrath P, Grunholz J, Noppeney U, Waberski TD, Gobbele R, Willmes K, Treede RD: Differential effects of pain and spatial attention on digit representation in the human primary somatosensory cortex. Neuroreport 2000;11:1289-1293.
22.
Butovas S, Schwarz C: Spatiotemporal effects of microstimulation in rat neocortex: a parametric study using multielectrode recordings. J Neurophysiol 2003;90:3024-3039.
23.
Sachs AJ, Babu H, Su YF, Miller KJ, Henderson JM: Lack of efficacy of motor cortex stimulation for the treatment of neuropathic pain in 14 patients. Neuromodulation 2014;17:303-310.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.